Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 7/2010

01.10.2010 | Original Paper

Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity

verfasst von: Johann Steiner, Roland Jacobs, Benjamin Panteli, Mareike Brauner, Kolja Schiltz, Sabine Bahn, Marlis Herberth, Sabine Westphal, Tomasz Gos, Martin Walter, Hans-Gert Bernstein, Aye Mu Myint, Bernhard Bogerts

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Previous studies of lymphocyte distribution in schizophrenia have yielded inconsistent results, as summarized in the present study. Based on our own original data, potential confounds that might explain these variations are analyzed and discussed. Blood samples from 26 patients with acute paranoid schizophrenia were investigated in comparison with 32 matched healthy controls by flow cytometry (CD3, CD4, CD8, CD19, and CD56 phenotyping). A subgroup of drug-free patients was followed up after 6 weeks of treatment. Cotinine levels and the free cortisol index (FCI) were provided in order to control for medication, smoking, and stress. Cotinine levels correlated with natural killer (NK) cell counts (CD3/CD56+: r = −0.383, P = 0.003) while the FCI was related to B cell numbers (CD19+: r = 0.390, P = 0.003). Considering these covariates, a lower level of T helper cells (P = 0.010), a reduced CD4/CD8 ratio (P = 0.029), and elevated B cells (P = 0.008) were found during acute psychosis. After 6 weeks of medication, an inverse pattern was observed in initially drug-free patients: total T cell (P = 0.005), T helper (P = 0.003), and T suppressor/cytotoxic cells (P = 0.005) increased, while B cell counts declined (P = 0.049). In conclusion, acute paranoid schizophrenia may be accompanied by a reduced T cell defense and a shift towards B cell immunity, which normalizes in response to treatment. In addition to disease stage or subtype and medication, cigarette smoking and stress are important co-factors.
Literatur
1.
Zurück zum Zitat APA (2000) Diagnostic and statistical manual of mental disorders, 4th revised edition (DSM-IV-TR). American Psychiatric Press, Washington APA (2000) Diagnostic and statistical manual of mental disorders, 4th revised edition (DSM-IV-TR). American Psychiatric Press, Washington
2.
Zurück zum Zitat Baskak SC, Ozsan H, Baskak B, Devrimci Ozguven H, Kinikli G (2008) Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication. Turk Psikiyatri Derg 19:5–12PubMed Baskak SC, Ozsan H, Baskak B, Devrimci Ozguven H, Kinikli G (2008) Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication. Turk Psikiyatri Derg 19:5–12PubMed
3.
Zurück zum Zitat Bilici M, Tekelioglu Y, Efendioglu S, Ovali E, Ulgen M (2003) The influence of olanzapine on immune cells in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:483–485CrossRefPubMed Bilici M, Tekelioglu Y, Efendioglu S, Ovali E, Ulgen M (2003) The influence of olanzapine on immune cells in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:483–485CrossRefPubMed
4.
Zurück zum Zitat Borda T, Perez Rivera R, Joensen L, Gomez RM, Sterin-Borda L (2002) Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction. J Immunol 168:3667–3674PubMed Borda T, Perez Rivera R, Joensen L, Gomez RM, Sterin-Borda L (2002) Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction. J Immunol 168:3667–3674PubMed
5.
Zurück zum Zitat Bramer SL, Kallungal BA (2003) Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 8:187–203CrossRefPubMed Bramer SL, Kallungal BA (2003) Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 8:187–203CrossRefPubMed
6.
Zurück zum Zitat Brisch R, Bernstein HG, Krell D, Stauch R, Trubner K, Dobrowolny H, Kropf S, Bielau H, Bogerts B (2007) Volumetric analysis of septal region in schizophrenia and affective disorder. Eur Arch Psychiatry Clin Neurosci 257:140–148CrossRefPubMed Brisch R, Bernstein HG, Krell D, Stauch R, Trubner K, Dobrowolny H, Kropf S, Bielau H, Bogerts B (2007) Volumetric analysis of septal region in schizophrenia and affective disorder. Eur Arch Psychiatry Clin Neurosci 257:140–148CrossRefPubMed
7.
Zurück zum Zitat Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES (2004) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61:774–780CrossRefPubMed Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES (2004) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61:774–780CrossRefPubMed
9.
Zurück zum Zitat Coste J, Strauch G, Letrait M, Bertagna X (1994) Reliability of hormonal levels for assessing the hypothalamic–pituitary–adrenocortical system in clinical pharmacology. Br J Clin Pharmacol 38:474–479PubMed Coste J, Strauch G, Letrait M, Bertagna X (1994) Reliability of hormonal levels for assessing the hypothalamic–pituitary–adrenocortical system in clinical pharmacology. Br J Clin Pharmacol 38:474–479PubMed
10.
Zurück zum Zitat Craddock RM, Lockstone HE, Rider DA, Wayland MT, Harris LJ, McKenna PJ, Bahn S (2007) Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. PLoS ONE 2:e692CrossRefPubMed Craddock RM, Lockstone HE, Rider DA, Wayland MT, Harris LJ, McKenna PJ, Bahn S (2007) Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. PLoS ONE 2:e692CrossRefPubMed
11.
Zurück zum Zitat Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS (2006) Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun 20:532–545CrossRefPubMed Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS (2006) Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun 20:532–545CrossRefPubMed
12.
Zurück zum Zitat Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163:521–528CrossRefPubMed Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163:521–528CrossRefPubMed
13.
Zurück zum Zitat Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D, Modiano JF (2004) Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. J Pharmacol Exp Ther 311:758–769CrossRefPubMed Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D, Modiano JF (2004) Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. J Pharmacol Exp Ther 311:758–769CrossRefPubMed
14.
Zurück zum Zitat Ganguli R, Rabin BS (1993) CD5 positive B lymphocytes in schizophrenia: no alteration in numbers or percentage as compared with control subjects. Psychiatry Res 48:69–78CrossRefPubMed Ganguli R, Rabin BS (1993) CD5 positive B lymphocytes in schizophrenia: no alteration in numbers or percentage as compared with control subjects. Psychiatry Res 48:69–78CrossRefPubMed
15.
Zurück zum Zitat Geng Y, Savage SM, Johnson LJ, Seagrave J, Sopori ML (1995) Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol Appl Pharmacol 135:268–278CrossRefPubMed Geng Y, Savage SM, Johnson LJ, Seagrave J, Sopori ML (1995) Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol Appl Pharmacol 135:268–278CrossRefPubMed
16.
Zurück zum Zitat Geng Y, Savage SM, Razani-Boroujerdi S, Sopori ML (1996) Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol 156:2384–2390PubMed Geng Y, Savage SM, Razani-Boroujerdi S, Sopori ML (1996) Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol 156:2384–2390PubMed
17.
Zurück zum Zitat Gladkevich A, Kauffman HF, Korf J (2004) Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28:559–576CrossRefPubMed Gladkevich A, Kauffman HF, Korf J (2004) Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28:559–576CrossRefPubMed
18.
Zurück zum Zitat Henneberg A, Riedl B, Dumke HO, Kornhuber HH (1990) T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatry Neurol Sci 239:283–284CrossRefPubMed Henneberg A, Riedl B, Dumke HO, Kornhuber HH (1990) T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatry Neurol Sci 239:283–284CrossRefPubMed
19.
Zurück zum Zitat Herbert TB, Cohen S (1993) Stress and immunity in humans: a meta-analytic review. Psychosom Med 55:364–379PubMed Herbert TB, Cohen S (1993) Stress and immunity in humans: a meta-analytic review. Psychosom Med 55:364–379PubMed
20.
Zurück zum Zitat Holt PG, Keast D (1977) Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol Rev 41:205–216PubMed Holt PG, Keast D (1977) Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol Rev 41:205–216PubMed
21.
Zurück zum Zitat Ilani T, Strous RD, Fuchs S (2004) Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J 18:1600–1602PubMed Ilani T, Strous RD, Fuchs S (2004) Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J 18:1600–1602PubMed
22.
Zurück zum Zitat Ising M, Kunzel HE, Binder EB, Nickel T, Modell S, Holsboer F (2005) The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 29:1085–1093CrossRefPubMed Ising M, Kunzel HE, Binder EB, Nickel T, Modell S, Holsboer F (2005) The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 29:1085–1093CrossRefPubMed
23.
Zurück zum Zitat Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL (1990) Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol 20:369–395CrossRefPubMed Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL (1990) Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol 20:369–395CrossRefPubMed
24.
Zurück zum Zitat Kalman D, Morissette SB, George TP (2005) Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14:106–123CrossRefPubMed Kalman D, Morissette SB, George TP (2005) Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14:106–123CrossRefPubMed
25.
Zurück zum Zitat Kalra R, Singh SP, Kracko D, Matta SG, Sharp BM, Sopori ML (2002) Chronic self-administration of nicotine in rats impairs T cell responsiveness. J Pharmacol Exp Ther 302:935–939CrossRefPubMed Kalra R, Singh SP, Kracko D, Matta SG, Sharp BM, Sopori ML (2002) Chronic self-administration of nicotine in rats impairs T cell responsiveness. J Pharmacol Exp Ther 302:935–939CrossRefPubMed
26.
Zurück zum Zitat Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed
27.
Zurück zum Zitat Keilhoff G, Grecksch G, Bernstein HG, Roskoden T, Becker A (2010) Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur Arch Psychiatry Clin Neurosci (in press) Keilhoff G, Grecksch G, Bernstein HG, Roskoden T, Becker A (2010) Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur Arch Psychiatry Clin Neurosci (in press)
28.
Zurück zum Zitat le Roux CW, Sivakumaran S, Alaghband-Zadeh J, Dhillo W, Kong WM, Wheeler MJ (2002) Free cortisol index as a surrogate marker for serum free cortisol. Ann Clin Biochem 39:406–408CrossRefPubMed le Roux CW, Sivakumaran S, Alaghband-Zadeh J, Dhillo W, Kong WM, Wheeler MJ (2002) Free cortisol index as a surrogate marker for serum free cortisol. Ann Clin Biochem 39:406–408CrossRefPubMed
29.
Zurück zum Zitat Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L (2001) Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates β1 integrin function. Eur J Immunol 31:3504–3512CrossRefPubMed Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L (2001) Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates β1 integrin function. Eur J Immunol 31:3504–3512CrossRefPubMed
30.
Zurück zum Zitat Maino K, Gruber R, Riedel M, Seitz N, Schwarz M, Müller N (2007) T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiatry Res 152:173–180CrossRefPubMed Maino K, Gruber R, Riedel M, Seitz N, Schwarz M, Müller N (2007) T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiatry Res 152:173–180CrossRefPubMed
31.
Zurück zum Zitat Maxeiner HG, Rojewski MT, Schmitt A, Tumani H, Bechter K, Schmitt M (2009) Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders. Brain Behav Immun 23:134–142CrossRefPubMed Maxeiner HG, Rojewski MT, Schmitt A, Tumani H, Bechter K, Schmitt M (2009) Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders. Brain Behav Immun 23:134–142CrossRefPubMed
32.
Zurück zum Zitat Mazzarello V, Cecchini A, Fenu G, Rassu M, Dessy LA, Lorettu L, Montella A (2004) Lymphocytes in schizophrenic patients under therapy: serological, morphological and cell subset findings. Ital J Anat Embryol 109:177–188PubMed Mazzarello V, Cecchini A, Fenu G, Rassu M, Dessy LA, Lorettu L, Montella A (2004) Lymphocytes in schizophrenic patients under therapy: serological, morphological and cell subset findings. Ital J Anat Embryol 109:177–188PubMed
33.
Zurück zum Zitat McAllister CG, Rapaport MH, Pickar D, Podruchny TA, Christison G, Alphs LD, Paul SM (1989) Increased numbers of CD5+ B lymphocytes in schizophrenic patients. Arch Gen Psychiatry 46:890–894PubMed McAllister CG, Rapaport MH, Pickar D, Podruchny TA, Christison G, Alphs LD, Paul SM (1989) Increased numbers of CD5+ B lymphocytes in schizophrenic patients. Arch Gen Psychiatry 46:890–894PubMed
34.
Zurück zum Zitat Mian MF, Lauzon NM, Stampfli MR, Mossman KL, Ashkar AA (2008) Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. J Leukoc Biol 83:774–784CrossRefPubMed Mian MF, Lauzon NM, Stampfli MR, Mossman KL, Ashkar AA (2008) Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. J Leukoc Biol 83:774–784CrossRefPubMed
35.
Zurück zum Zitat Moszczynski P, Zabinski Z, Moszczynski P Jr, Rutowski J, Slowinski S, Tabarowski Z (2001) Immunological findings in cigarette smokers. Toxicol Lett 118:121–127CrossRefPubMed Moszczynski P, Zabinski Z, Moszczynski P Jr, Rutowski J, Slowinski S, Tabarowski Z (2001) Immunological findings in cigarette smokers. Toxicol Lett 118:121–127CrossRefPubMed
36.
Zurück zum Zitat Müller N, Ackenheil M (1998) Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22:1–33CrossRefPubMed Müller N, Ackenheil M (1998) Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22:1–33CrossRefPubMed
37.
Zurück zum Zitat Müller N, Schwarz MJ (2008) A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Clin Neurosci 258(Suppl 2):97–106CrossRefPubMed Müller N, Schwarz MJ (2008) A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Clin Neurosci 258(Suppl 2):97–106CrossRefPubMed
38.
Zurück zum Zitat Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808CrossRefPubMed Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808CrossRefPubMed
39.
Zurück zum Zitat Printz DJ, Strauss DH, Goetz R, Sadiq S, Malaspina D, Krolewski J, Gorman JM (1999) Elevation of CD5+ B lymphocytes in schizophrenia. Biol Psychiatry 46:110–118CrossRefPubMed Printz DJ, Strauss DH, Goetz R, Sadiq S, Malaspina D, Krolewski J, Gorman JM (1999) Elevation of CD5+ B lymphocytes in schizophrenia. Biol Psychiatry 46:110–118CrossRefPubMed
40.
Zurück zum Zitat Rey MJ, Schulz P, Costa C, Dick P, Tissot R (1989) Guidelines for the dosage of neuroleptics. I. Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 4:95–104CrossRefPubMed Rey MJ, Schulz P, Costa C, Dick P, Tissot R (1989) Guidelines for the dosage of neuroleptics. I. Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 4:95–104CrossRefPubMed
41.
Zurück zum Zitat Riedel M, Spellmann I, Schwarz MJ, Strassnig M, Sikorski C, Möller HJ, Müller N (2007) Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res 41:3–7CrossRefPubMed Riedel M, Spellmann I, Schwarz MJ, Strassnig M, Sikorski C, Möller HJ, Müller N (2007) Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res 41:3–7CrossRefPubMed
42.
Zurück zum Zitat Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H (1998) Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology 37:186–193CrossRefPubMed Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H (1998) Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology 37:186–193CrossRefPubMed
43.
Zurück zum Zitat Rudolf S, Schlenke P, Broocks A, Peters M, Rothermundt M, Arolt V, Kirchner H (2004) Search for atypical lymphocytes in schizophrenia. World J Biol Psychiatry 5:33–37CrossRefPubMed Rudolf S, Schlenke P, Broocks A, Peters M, Rothermundt M, Arolt V, Kirchner H (2004) Search for atypical lymphocytes in schizophrenia. World J Biol Psychiatry 5:33–37CrossRefPubMed
44.
Zurück zum Zitat Sasaki T, Nanko S, Fukuda R, Kawate T, Kunugi H, Kazamatsuri H (1994) Changes of immunological functions after acute exacerbation in schizophrenia. Biol Psychiatry 35:173–178CrossRefPubMed Sasaki T, Nanko S, Fukuda R, Kawate T, Kunugi H, Kazamatsuri H (1994) Changes of immunological functions after acute exacerbation in schizophrenia. Biol Psychiatry 35:173–178CrossRefPubMed
45.
Zurück zum Zitat Schattner A, Cori Y, Hahn T, Sirota P (1996) No evidence for autoimmunity in schizophrenia. J Autoimmun 9:661–666CrossRefPubMed Schattner A, Cori Y, Hahn T, Sirota P (1996) No evidence for autoimmunity in schizophrenia. J Autoimmun 9:661–666CrossRefPubMed
46.
Zurück zum Zitat Schulz P, Schlotz W (1999) Das Trierer Inventar zur Erfassung von chronischem Streß (TICS): Skalenkonstruktion, teststatistische Überprüfung und Validierung der Skala Arbeitsüberlastung. Diagnostica 45:8–19CrossRef Schulz P, Schlotz W (1999) Das Trierer Inventar zur Erfassung von chronischem Streß (TICS): Skalenkonstruktion, teststatistische Überprüfung und Validierung der Skala Arbeitsüberlastung. Diagnostica 45:8–19CrossRef
47.
Zurück zum Zitat Sperner-Unterweger B, Whitworth A, Kemmler G, Hilbe W, Thaler J, Weiss G, Fleischhacker WW (1999) T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients. Schizophr Res 38:61–70CrossRefPubMed Sperner-Unterweger B, Whitworth A, Kemmler G, Hilbe W, Thaler J, Weiss G, Fleischhacker WW (1999) T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients. Schizophr Res 38:61–70CrossRefPubMed
48.
Zurück zum Zitat Tanaka S, Matsunaga H, Kimura M, Tatsumi K, Hidaka Y, Takano T, Uema T, Takeda M, Amino N (2003) Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol 141:155–164CrossRefPubMed Tanaka S, Matsunaga H, Kimura M, Tatsumi K, Hidaka Y, Takano T, Uema T, Takeda M, Amino N (2003) Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol 141:155–164CrossRefPubMed
49.
Zurück zum Zitat Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2006) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 32:200–202 Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2006) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 32:200–202
50.
Zurück zum Zitat Torrey EF, Leweke MF, Schwarz MJ, Mueller N, Bachmann S, Schroeder J, Dickerson F, Yolken RH (2006) Cytomegalovirus and schizophrenia. CNS Drugs 20:879–885CrossRefPubMed Torrey EF, Leweke MF, Schwarz MJ, Mueller N, Bachmann S, Schroeder J, Dickerson F, Yolken RH (2006) Cytomegalovirus and schizophrenia. CNS Drugs 20:879–885CrossRefPubMed
51.
Zurück zum Zitat Watanabe Y, Nakayama T, Nagakubo D, Hieshima K, Jin Z, Katou F, Hashimoto K, Yoshie O (2006) Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol 176:848–856PubMed Watanabe Y, Nakayama T, Nagakubo D, Hieshima K, Jin Z, Katou F, Hashimoto K, Yoshie O (2006) Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol 176:848–856PubMed
52.
Zurück zum Zitat Webster Marketon JI, Glaser R (2008) Stress hormones and immune function. Cell Immunol 252:16–26CrossRefPubMed Webster Marketon JI, Glaser R (2008) Stress hormones and immune function. Cell Immunol 252:16–26CrossRefPubMed
53.
Zurück zum Zitat Wittchen HU, Zaudig M, Fydrich T (1997) Strukturiertes Klinisches Interview für DSM-IV. Hogrefe, Göttingen Wittchen HU, Zaudig M, Fydrich T (1997) Strukturiertes Klinisches Interview für DSM-IV. Hogrefe, Göttingen
54.
Zurück zum Zitat Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667CrossRefPubMed Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667CrossRefPubMed
55.
Zurück zum Zitat Wüst S, Federenko IS, van Rossum EF, Koper JW, Hellhammer DH (2005) Habituation of cortisol responses to repeated psychosocial stress-further characterization and impact of genetic factors. Psychoneuroendocrinology 30:199–211CrossRefPubMed Wüst S, Federenko IS, van Rossum EF, Koper JW, Hellhammer DH (2005) Habituation of cortisol responses to repeated psychosocial stress-further characterization and impact of genetic factors. Psychoneuroendocrinology 30:199–211CrossRefPubMed
56.
Zurück zum Zitat Yolken RH, Torrey EF (2008) Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 13:470–479CrossRefPubMed Yolken RH, Torrey EF (2008) Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 13:470–479CrossRefPubMed
57.
Zurück zum Zitat Young WF (2007) Adrenal medulla, catecholamines, and pheochromocytoma. In: Goldman L, Ausiello D (eds) Cecil medicine, chap 246. Saunders Elsevier, Philadelphia Young WF (2007) Adrenal medulla, catecholamines, and pheochromocytoma. In: Goldman L, Ausiello D (eds) Cecil medicine, chap 246. Saunders Elsevier, Philadelphia
58.
Zurück zum Zitat Yovel G, Sirota P, Mazeh D, Shakhar G, Rosenne E, Ben-Eliyahu S (2000) Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking. Brain Behav Immun 14:153–169CrossRefPubMed Yovel G, Sirota P, Mazeh D, Shakhar G, Rosenne E, Ben-Eliyahu S (2000) Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking. Brain Behav Immun 14:153–169CrossRefPubMed
59.
Zurück zum Zitat Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15:199–226CrossRefPubMed Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15:199–226CrossRefPubMed
Metadaten
Titel
Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity
verfasst von
Johann Steiner
Roland Jacobs
Benjamin Panteli
Mareike Brauner
Kolja Schiltz
Sabine Bahn
Marlis Herberth
Sabine Westphal
Tomasz Gos
Martin Walter
Hans-Gert Bernstein
Aye Mu Myint
Bernhard Bogerts
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 7/2010
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-010-0098-x

Weitere Artikel der Ausgabe 7/2010

European Archives of Psychiatry and Clinical Neuroscience 7/2010 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.